Loading…

Serum Hepcidin Levels Are Associated With Serum Triglycerides and Interleukin-6 Concentrations in Patients With End-Stage Renal Disease

Hepcidin has emerged as a peptide with a key role in the regulation of iron homeostasis in patients with chronic kidney disease (CKD), having a strong dependence on inflammation. Recent studies reveal that hepcidin may be also associated with the progression of atherosclerosis. This study was perfor...

Full description

Saved in:
Bibliographic Details
Published in:Therapeutic apheresis and dialysis 2014-06, Vol.18 (3), p.279-283
Main Authors: Samouilidou, Elisabeth, Pantelias, Konstantinos, Petras, Dimitrios, Tsirpanlis, George, Bakirtzi, Joulia, Chatzivasileiou, George, Tzanatos, Helen, Grapsa, Eirini
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepcidin has emerged as a peptide with a key role in the regulation of iron homeostasis in patients with chronic kidney disease (CKD), having a strong dependence on inflammation. Recent studies reveal that hepcidin may be also associated with the progression of atherosclerosis. This study was performed to analyze the relation of hepcidin to markers of atherosclerosis and inflammation in patients on dialysis. A total of 90 individuals were enrolled. Sixty patients with end‐stage renal disease, who were on hemodialysis (HD) (N = 30) and peritoneal dialysis (N = 30) were compared with 30 normal controls (NC). Age, body mass index, time on dialysis, serum lipids, C‐reactive protein (CRP) and interleukin‐6 (IL‐6) were measured and analyzed in correlation with hepcidin concentration. It was found that patients on HD and peritoneal dialysis have significantly higher (P 
ISSN:1744-9979
1744-9987
DOI:10.1111/1744-9987.12102